Cytopenia among CML Patients on Imatinib in Kenya: Types, Grades, and Time Course

BACKGROUND: Imatinib mesylate is the gold standard for the treatment of all phases of Philadelphia-positive chronic myeloid leukemia. Patients on imatinib treatment may develop cytopenia due to drug toxicity. This study aimed to determine the types, grades, and time course of cytopenia in CML patien...

Descripción completa

Detalles Bibliográficos
Autores principales: McLigeyo, Angela, Rajab, Jamilla, Ezzi, Mohammed, Oyiro, Peter, Bett, Yatich, Odhiambo, Andrew, Ong'ondi, Matilda, Mwanzi, Sitna, Gatua, Mercy, Abinya, NAOthieno-
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240645/
https://www.ncbi.nlm.nih.gov/pubmed/32454829
http://dx.doi.org/10.1155/2020/7696204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240645/
https://www.ncbi.nlm.nih.gov/pubmed/32454829
http://dx.doi.org/10.1155/2020/7696204

Ejemplares similares